Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 11.25
(2.18%)
CNY 11.25
(2.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.61 Billion CNY | 9.04% |
| 2022 | 1.47 Billion CNY | 22.03% |
| 2021 | 1.21 Billion CNY | 88.99% |
| 2020 | 641.25 Million CNY | 31.39% |
| 2019 | 488.04 Million CNY | 72.84% |
| 2018 | 282.36 Million CNY | 4.23% |
| 2017 | 270.89 Million CNY | 32.9% |
| 2016 | 203.83 Million CNY | -23.2% |
| 2015 | 265.41 Million CNY | 24.19% |
| 2014 | 213.72 Million CNY | -6.66% |
| 2013 | 228.97 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.66 Billion CNY | 4.39% |
| 2024 Q3 | 1.7 Billion CNY | 2.61% |
| 2024 Q1 | 1.59 Billion CNY | -1.15% |
| 2023 Q1 | 1.4 Billion CNY | -5.18% |
| 2023 Q3 | 1.5 Billion CNY | 1.65% |
| 2023 Q2 | 1.48 Billion CNY | 5.69% |
| 2023 Q4 | 1.61 Billion CNY | 7.04% |
| 2023 FY | 1.61 Billion CNY | 9.04% |
| 2022 Q3 | 1.36 Billion CNY | 4.59% |
| 2022 Q1 | 1.21 Billion CNY | 0.03% |
| 2022 FY | 1.47 Billion CNY | 22.03% |
| 2022 Q4 | 1.47 Billion CNY | 8.53% |
| 2022 Q2 | 1.3 Billion CNY | 7.46% |
| 2021 Q3 | 1.08 Billion CNY | 4.68% |
| 2021 FY | 1.21 Billion CNY | 88.99% |
| 2021 Q4 | 1.21 Billion CNY | 12.18% |
| 2021 Q2 | 1.03 Billion CNY | 63.28% |
| 2021 Q1 | 632.05 Million CNY | -1.43% |
| 2020 Q4 | 641.25 Million CNY | 12.61% |
| 2020 FY | 641.25 Million CNY | 31.39% |
| 2020 Q1 | 478.55 Million CNY | -1.94% |
| 2020 Q2 | 508.87 Million CNY | 6.34% |
| 2020 Q3 | 569.43 Million CNY | 11.9% |
| 2019 FY | 488.04 Million CNY | 72.84% |
| 2019 Q4 | 488.04 Million CNY | 0.0% |
| 2018 FY | 282.36 Million CNY | 4.23% |
| 2018 Q2 | 267.23 Million CNY | 0.0% |
| 2018 Q1 | 267.23 Million CNY | -1.45% |
| 2017 Q1 | 255.7 Million CNY | 25.45% |
| 2017 FY | 270.89 Million CNY | 32.9% |
| 2017 Q4 | 271.17 Million CNY | 0.0% |
| 2017 Q3 | 271.17 Million CNY | 6.05% |
| 2017 Q2 | 255.7 Million CNY | 0.0% |
| 2016 Q4 | 203.83 Million CNY | 0.0% |
| 2016 Q3 | 203.83 Million CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 203.83 Million CNY | -23.2% |
| 2015 Q3 | 265.41 Million CNY | 0.0% |
| 2015 FY | 265.41 Million CNY | 24.19% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 265.41 Million CNY | 0.0% |
| 2014 FY | 213.72 Million CNY | -6.66% |
| 2013 FY | 228.97 Million CNY | 0.0% |